HUP0104033A2 - Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk - Google Patents
Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásukInfo
- Publication number
- HUP0104033A2 HUP0104033A2 HU0104033A HUP0104033A HUP0104033A2 HU P0104033 A2 HUP0104033 A2 HU P0104033A2 HU 0104033 A HU0104033 A HU 0104033A HU P0104033 A HUP0104033 A HU P0104033A HU P0104033 A2 HUP0104033 A2 HU P0104033A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- compounds
- carbon atoms
- general formula
- atoms
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- VDWSVBMVZLRATD-UHFFFAOYSA-N phenyl(pyridazin-3-yl)methanone Chemical class C=1C=CN=NC=1C(=O)C1=CC=CC=C1 VDWSVBMVZLRATD-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- -1 R5 is group A Chemical group 0.000 abstract 1
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
Abstract
A találmány tárgya (I) általános képletű vegyületek, ahol R1 és R2jelentése minden esetben egymástól függetlenül hidroxilcsoport,halogénatom vagy OR5, -S-R5, -SO-R5, -SO2-R5 általános képletűcsoport, vagy R1 és R2 együtt -O-CH2-O- csoportot alkot, R3 jelentéseNH2, NHA, NAA' általános képletű csoport vagy telített heterociklusoscsoport, amely 1-4 nitrogén-, oxigén- és/vagy kénatomot tartalmaz, ésamely szubsztituálatlan vagy halogénatommal, A és/vagy OA csoporttalmono-, di- vagy triszubsztituált, Q hiányzik vagy jelentése 1-10szénatomos egyenes vagy elágazó láncú alkiléncsoport, R5 jelentése Acsoport, 3-7 szénatomos cikloalkil-, 4-8 szénatomos alkiléncikloalkil-vagy 2-8 szénatomos alkenilcsoport, A és A' jelentése minden esetbenegymástól függetlenül 1-10 szénatomos alkilcsoport, amely adottesetben 1-5-szörösen fluor- és/vagy klóratommal szubsztituálva van, ésfiziológiailag alkalmazható sóik és szolvátjaik. A vegyületetfoszfodiészteráz IV gátló hatással rendelkeznek. A találmány avegyületek előállítására szolgáló eljárást, a vegyületeket tartalmazógyógyszerkészítményeket és a vegyületek alkalmazását is magábanfoglalja. Ó
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19850701A DE19850701A1 (de) | 1998-11-04 | 1998-11-04 | Benzoylpyridazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104033A2 true HUP0104033A2 (hu) | 2002-05-29 |
| HUP0104033A3 HUP0104033A3 (en) | 2002-08-28 |
Family
ID=7886577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104033A HUP0104033A3 (en) | 1998-11-04 | 1999-10-23 | 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6376493B1 (hu) |
| EP (1) | EP1124809B1 (hu) |
| JP (1) | JP4354652B2 (hu) |
| KR (1) | KR20010075636A (hu) |
| CN (1) | CN1142153C (hu) |
| AR (1) | AR021068A1 (hu) |
| AT (1) | ATE262513T1 (hu) |
| AU (1) | AU759328B2 (hu) |
| BR (1) | BR9915004A (hu) |
| CA (1) | CA2349232A1 (hu) |
| CZ (1) | CZ20011551A3 (hu) |
| DE (2) | DE19850701A1 (hu) |
| DK (1) | DK1124809T3 (hu) |
| ES (1) | ES2214891T3 (hu) |
| HU (1) | HUP0104033A3 (hu) |
| ID (1) | ID28816A (hu) |
| NO (1) | NO20012188D0 (hu) |
| PL (1) | PL346909A1 (hu) |
| PT (1) | PT1124809E (hu) |
| SI (1) | SI1124809T1 (hu) |
| SK (1) | SK5782001A3 (hu) |
| TW (1) | TW458970B (hu) |
| WO (1) | WO2000026201A1 (hu) |
| ZA (1) | ZA200104541B (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19915364A1 (de) * | 1999-04-06 | 2000-10-12 | Merck Patent Gmbh | Verwendung von Arylalkanoylpyridazinen |
| DE10064997A1 (de) * | 2000-12-23 | 2002-06-27 | Merck Patent Gmbh | Benzoylpyridazine |
| KR20040012720A (ko) * | 2001-02-12 | 2004-02-11 | 메르크 파텐트 게엠베하 | 심근 질환에서 제 4형 포스포디에스테라제 저해제의 용도 |
| ATE335486T1 (de) | 2001-11-05 | 2006-09-15 | Merck Patent Gmbh | Hydrazono-malonitrile |
| KR100866286B1 (ko) * | 2001-11-29 | 2008-10-31 | 씨제이제일제당 (주) | 신규한 카테콜 히드라지드 유도체 및 그의 제조방법 |
| KR100508156B1 (ko) * | 2002-11-29 | 2005-08-17 | 씨제이 주식회사 | 신규한 캐테콜 히드라자이드 유도체 |
| JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス，インコーポレイティド | ムスカリン性受容体調節による神経発生 |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| CN113264899B (zh) * | 2021-04-09 | 2022-06-14 | 台州学院 | 一种1，3，5-噁二嗪类化合物及其制备和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU668206B2 (en) | 1992-07-01 | 1996-04-26 | Ortho Pharmaceutical Corporation | 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
| DE19514568A1 (de) | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Arylalkyl-pyridazinone |
| DE19632549A1 (de) | 1996-08-13 | 1998-02-19 | Merck Patent Gmbh | Arylalkanoylpyridazine |
-
1998
- 1998-11-04 DE DE19850701A patent/DE19850701A1/de not_active Withdrawn
-
1999
- 1999-10-23 SK SK578-2001A patent/SK5782001A3/sk unknown
- 1999-10-23 ES ES99950775T patent/ES2214891T3/es not_active Expired - Lifetime
- 1999-10-23 AU AU63423/99A patent/AU759328B2/en not_active Ceased
- 1999-10-23 PL PL99346909A patent/PL346909A1/xx unknown
- 1999-10-23 CN CNB998127469A patent/CN1142153C/zh not_active Expired - Fee Related
- 1999-10-23 KR KR1020017004759A patent/KR20010075636A/ko not_active Application Discontinuation
- 1999-10-23 US US09/830,957 patent/US6376493B1/en not_active Expired - Fee Related
- 1999-10-23 ID IDW00200101082A patent/ID28816A/id unknown
- 1999-10-23 WO PCT/EP1999/008047 patent/WO2000026201A1/de not_active Application Discontinuation
- 1999-10-23 DK DK99950775T patent/DK1124809T3/da active
- 1999-10-23 HU HU0104033A patent/HUP0104033A3/hu unknown
- 1999-10-23 BR BR9915004-2A patent/BR9915004A/pt not_active IP Right Cessation
- 1999-10-23 CZ CZ20011551A patent/CZ20011551A3/cs unknown
- 1999-10-23 EP EP99950775A patent/EP1124809B1/de not_active Expired - Lifetime
- 1999-10-23 AT AT99950775T patent/ATE262513T1/de not_active IP Right Cessation
- 1999-10-23 SI SI9930542T patent/SI1124809T1/xx unknown
- 1999-10-23 CA CA002349232A patent/CA2349232A1/en not_active Abandoned
- 1999-10-23 DE DE59908968T patent/DE59908968D1/de not_active Expired - Lifetime
- 1999-10-23 JP JP2000579590A patent/JP4354652B2/ja not_active Expired - Fee Related
- 1999-10-23 PT PT99950775T patent/PT1124809E/pt unknown
- 1999-10-29 TW TW088118837A patent/TW458970B/zh not_active IP Right Cessation
- 1999-11-03 AR ARP990105552A patent/AR021068A1/es not_active Application Discontinuation
-
2001
- 2001-05-03 NO NO20012188A patent/NO20012188D0/no not_active Application Discontinuation
- 2001-06-01 ZA ZA200104541A patent/ZA200104541B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200104541B (en) | 2002-09-02 |
| CN1324350A (zh) | 2001-11-28 |
| ES2214891T3 (es) | 2004-09-16 |
| DE59908968D1 (de) | 2004-04-29 |
| EP1124809B1 (de) | 2004-03-24 |
| ATE262513T1 (de) | 2004-04-15 |
| TW458970B (en) | 2001-10-11 |
| JP4354652B2 (ja) | 2009-10-28 |
| SI1124809T1 (en) | 2004-06-30 |
| PT1124809E (pt) | 2004-07-30 |
| DE19850701A1 (de) | 2000-05-11 |
| JP2002528536A (ja) | 2002-09-03 |
| SK5782001A3 (en) | 2001-11-06 |
| AR021068A1 (es) | 2002-06-12 |
| US6376493B1 (en) | 2002-04-23 |
| CA2349232A1 (en) | 2000-05-11 |
| CZ20011551A3 (cs) | 2001-08-15 |
| WO2000026201A1 (de) | 2000-05-11 |
| AU6342399A (en) | 2000-05-22 |
| NO20012188L (no) | 2001-05-03 |
| CN1142153C (zh) | 2004-03-17 |
| ID28816A (id) | 2001-07-05 |
| HUP0104033A3 (en) | 2002-08-28 |
| DK1124809T3 (da) | 2004-07-19 |
| NO20012188D0 (no) | 2001-05-03 |
| AU759328B2 (en) | 2003-04-10 |
| EP1124809A1 (de) | 2001-08-22 |
| KR20010075636A (ko) | 2001-08-09 |
| BR9915004A (pt) | 2001-11-13 |
| PL346909A1 (en) | 2002-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104033A2 (hu) | Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk | |
| HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0401083A2 (hu) | 4-Amino-6-fenil-pirrolo[2,3-d]pirimidin-származékok, ezeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| CA2011346A1 (en) | 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
| HUP9904703A2 (hu) | Aminotiofén-karbonsav-amidok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| HUP0203288A2 (hu) | Foszfodiészteráz VII inhibitor hatású pirrolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| ATE356117T1 (de) | Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität | |
| KR950014097A (ko) | 피페라진 유도체 | |
| HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
| HUP0004082A2 (hu) | Adenozinszármazékok, eljárás előállításukra azokat hatóanyagként tartalmazó gyógyszerkészítmények, valamint ilyen hatóanyagok alkalmazása gyógyszerkészítmények előállítására | |
| HUP0001760A2 (hu) | Aril-acil-piridazin-származékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és a vegyületek alkalmazása gyógyszerkészítmények előállítására | |
| HUP0103165A2 (hu) | Tiazolinsavszármazékok, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| GB9408185D0 (en) | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| IL80216A0 (en) | 3-vinyl-and 3-ethinyl-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT72434A (en) | Novel pyridone carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their production | |
| HUP0402602A2 (hu) | Eljárás echinokandin-származékok előállítására, ezek alkalmazása, ezeket tartalmazó gyógyszerkészítmények és intermedierek | |
| HUP0303593A2 (hu) | Biguanidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP9903902A2 (hu) | Bróm-tiakumicin vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HUP0402341A2 (hu) | Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére | |
| ES2043834T3 (es) | Un procedimiento para preparar nuevos derivados de androsta-1,4-dien-3-ona sustituida en la posicion 17. | |
| HUP0101230A2 (hu) | Eljárás 2-[(2-piridil)-metilszulfinil]-1H-benzimidazol-származékok előállítására | |
| DE69330601D1 (de) | Serotoninergische ergolin derivate | |
| ES2095186A1 (es) | Derivados de epi-epibatidina. |